Jeffrey E. Settleman
Impact in
- Oncology top 0.1%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
- Cell Biology 43
- Cellular Mechanics and Interactions 23
- Oncology 52
- HER2/EGFR in Cancer Research 19
- Cancer-related Molecular Pathways 11
- Co-authors
- Daniel A. Haber (23 shared papers)Daphne W. Bell (7 shared papers)Sreenath V. Sharma (15 shared papers)Raffaella Sordella (10 shared papers)Jeffrey A. Engelman (13 shared papers)Anthony John Iafrate (9 shared papers)Thomas James Lynch (8 shared papers)Ultan McDermott (10 shared papers)
- Journals
- Cancer Research (12 papers)Journal of Biological Chemistry (8 papers)Molecular and Cellular Biology (8 papers)Cell (7 papers)Proceedings of the National Academy of Sciences (7 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Jeffrey E. Settleman
159 papers receiving 32.9k citations
Jeffrey E. Settleman's Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 11.9k
- Cancer Research 5.3k
- Pulmonary and Respiratory Medicine 10.6k
- Molecular Biology 17.5k
- Cell Biology 4.1k
Countries citing papers authored by Jeffrey E. Settleman
This map shows the geographic impact of Jeffrey E. Settleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Settleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Settleman more than expected).
Fields of papers citing papers by Jeffrey E. Settleman
This network shows the impact of papers produced by Jeffrey E. Settleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Settleman. The network helps show where Jeffrey E. Settleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey E. Settleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer Hit paper breakdown → | 2010 | 3791 |
| 2 | Epidermal growth factor receptor mutations in lung cancer Hit paper breakdown → | 2007 | 2671 |
| 3 | Systematic identification of genomic markers of drug sensitivity in cancer cells Hit paper breakdown → | 2012 | 1947 |
| 4 | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Hit paper breakdown → | 2008 | 1849 |
| 5 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK Hit paper breakdown → | 2009 | 1615 |
| 6 | Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways Hit paper breakdown → | 2004 | 1437 |
| 7 | Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Hit paper breakdown → | 2008 | 1421 |
| 8 | EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib Hit paper breakdown → | 2012 | 873 |
| 9 | Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib Hit paper breakdown → | 2005 | 838 |
| 10 | Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 Hit paper breakdown → | 1993 | 787 |
| 11 | First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations Hit paper breakdown → | 2008 | 726 |
| 12 | SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction Hit paper breakdown → | 2011 | 554 |
| 13 | 2008 | 499 | |
| 14 | A comprehensive transcriptional portrait of human cancer cell lines Hit paper breakdown → | 2014 | 498 |
| 15 | 2008 | 443 | |
| 16 | 2006 | 437 | |
| 17 | 2011 | 365 | |
| 18 | 2008 | 347 | |
| 19 | 2010 | 343 | |
| 20 | 2006 | 339 |
About Jeffrey E. Settleman
Jeffrey E. Settleman is a scholar working on Cell Biology, Oncology, Molecular Biology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 160 papers that have together received 33.9k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (47 papers), Lung Cancer Treatments and Mutations (29 papers), Cellular Mechanics and Interactions (23 papers), HER2/EGFR in Cancer Research (19 papers), Cell Adhesion Molecules Research (19 papers), Melanoma and MAPK Pathways (16 papers), PI3K/AKT/mTOR signaling in cancer (15 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Oncology (11.9k citations), Cancer Research (5.3k citations), Pulmonary and Respiratory Medicine (10.6k citations), Molecular Biology (17.5k citations) and Cell Biology (4.1k citations). Jeffrey E. Settleman has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Daniel A. Haber, Daphne W. Bell, Sreenath V. Sharma, Raffaella Sordella, Jeffrey A. Engelman, Anthony John Iafrate, Thomas James Lynch, Ultan McDermott, Ryan Bruce Corcoran and André Bernards. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Molecular and Cellular Biology, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.